In a big shift of focus, the personal genomics company 23andMe recently announced the creation of a new therapeutics group with the intention of developing new therapies for both common and rare diseases.

Discover the Science of Health
In a big shift of focus, the personal genomics company 23andMe recently announced the creation of a new therapeutics group with the intention of developing new therapies for both common and rare diseases.
Roche is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].
Advertising Policy | Advertise with Highlight HEALTH
Disclaimer | Highlight HEALTH Privacy Policy
Copyright © 2025 Highlight Health Media